Understand the source comparison
Best Peptides for Inflammation: Mechanism Comparison
BPC-157 NOS stabilization, VEGF upregulation, cytokine modulation Acute injury resolution (0–14 days post-injury) 250–500 mcg SC twice daily 30+ preclinical studies; no human RCTs Best choice for acute traumatic injury and ligament/tendon repair. Most robust p
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157
- NOS stabilization, VEGF upregulation, cytokine modulation
- Acute injury resolution (0–14 days post-injury)
- 250–500 mcg SC twice daily
- 30+ preclinical studies; no human RCTs
- Best choice for acute traumatic injury and ligament/tendon repair. Most robust preclinical data for tissue healing acceleration
- TB-500
- Actin sequestration, inflammatory cell migration inhibition
- Chronic tissue inflammation, tendinopathy
- 2.5–5 mg SC twice weekly
- Moderate (equine and rodent models; limited human data)
- Effective for chronic soft tissue inflammation where excessive immune cell infiltration drives pathology. Longer dosing intervals than BPC-157
- KPV
- NF-κB inhibition, inflammatory gene transcription suppression
- Localized mucosal inflammation (GI, dermatological)
- 500 mcg–2 mg SC daily or 5–10 mg oral (enteric-coated)
- Growing (multiple IBD and dermatitis studies)
- Most effective for epithelial inflammation. Works locally without systemic immunosuppression, making it safer for long-term use
- Thymosin Alpha-1
- T-cell differentiation, Treg enhancement, systemic cytokine modulation
- Chronic systemic inflammation, autoimmune conditions
- 1.6 mg SC twice weekly
- Strong (12+ clinical trials in immune-mediated conditions)
- Best for autoimmune-driven systemic inflammation. Modulates T-cell balance rather than suppressing inflammation directly
- Thymalin
- Thymic peptide complex, T-cell maturation support
- Autoimmune inflammation, immunosenescence
- 10 mg IM twice weekly
- Moderate (Russian clinical data; limited Western trials)
- Effective in autoimmune models where thymic dysfunction contributes to T-cell imbalance. Particularly studied in rheumatoid arthritis contexts